Subsequent fluorescence imaging using the near-infrared in vivo blood pool-imaging agent AngioSense [70,71] gave first indications that decreased perfusion of A375-EphB4 tumors may be caused by a diminished tumor vascularization. Here, EPHB4 is linked to neoplasm.